Rare
lephants
Screener
Toggle theme
Denali Therapeutics Inc.
DNLI
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2020
FY2018
Total Cash from Operations:
$1.05B
Line Item
Value
% of Total
Capital Expenditures
$3.1M
0.3%
Other Investing
$620.1M
59.0%
Net Cash Flow
$427.7M
40.7%
Download CSV
